Bio-Techne (TECH) Cash from Investing Activities (2009 - 2026)
Bio-Techne (TECH) posted quarterly Cash from Investing Activities of -$5.8 million for Q1 2026, up 34.44% year-over-year from -$4.3 million in Q1 2025, and up 1.76% quarter-over-quarter from -$5.9 million in Q4 2025.
Powered by 
Analysis
Bio-Techne (TECH) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Bio-Techne's Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$5.8 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 34.44% year-over-year to -$5.8 million; the TTM figure through Mar 2026 stood at -$10.7 million (up 75.84% YoY), while the FY2025 annual figure was -$35.2 million, up 82.67% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$5.8 million, up from -$5.9 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $605000.0 in Q3 2025, with the low at -$241.1 million in Q1 2023.
- The 5-year median for Cash from Investing Activities is -$8.9 million (2025), against an average of -$33.5 million.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities sank 28001.55% in 2022, then surged 104.61% in 2025.
- Bio-Techne's Cash from Investing Activities stood at -$109000.0 in 2022, then sank by 21616.51% to -$23.7 million in 2023, then jumped by 78.74% to -$5.0 million in 2024, then decreased by 17.67% to -$5.9 million in 2025, then climbed by 1.76% to -$5.8 million in 2026.
- Business Quant data shows TECH's Cash from Investing Activities at -$5.8 million in Q1 2026, -$5.9 million in Q4 2025, and $605000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 329.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -1.66 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -49.35 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -363.46 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -229.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 24.51 Mn |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | -7.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.06 Mn |
| Mar 31, 2026 | -5.82 Mn |
| Dec 31, 2025 | -5.92 Mn |
| Sep 30, 2025 | 605,000.00 |
| Jun 30, 2025 | 406,000.00 |
| Mar 31, 2025 | -8.87 Mn |
| Dec 31, 2024 | -5.03 Mn |
| Sep 30, 2024 | -21.68 Mn |
| Jun 30, 2024 | -8.81 Mn |
| Mar 31, 2024 | -16.44 Mn |
| Dec 31, 2023 | -23.67 Mn |
| Sep 30, 2023 | -154.11 Mn |
| Jun 30, 2023 | -4.76 Mn |
| Mar 31, 2023 | -241.10 Mn |
| Dec 31, 2022 | -109,000.00 |
| Sep 30, 2022 | -19.69 Mn |
| Jun 30, 2022 | -18.57 Mn |
| Mar 31, 2022 | -35.99 Mn |
| Dec 31, 2021 | -35.17 Mn |
| Sep 30, 2021 | -7.12 Mn |